Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0225 | 0.6149 | 0.8888 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.2694 | 0.2665 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0152 | 0.4022 | 0.5789 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.1642 | 0.2373 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0048 | 0.0956 | 0.1332 |
Brugia malayi | glutathione reductase | 0.0037 | 0.0626 | 0.0854 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.0049 | 0.0988 | 0.0952 |
Brugia malayi | Thioredoxin reductase | 0.0037 | 0.0626 | 0.0854 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0037 | 0.0626 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0104 | 0.2603 | 0.2574 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0152 | 0.4022 | 0.5789 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0046 | 0.0877 | 0.0841 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.2694 | 0.2665 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0988 | 0.1428 |
Plasmodium falciparum | thioredoxin reductase | 0.0037 | 0.0626 | 0.5 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.004 | 0.0715 | 0.0983 |
Echinococcus multilocularis | GPCR, family 2 | 0.0048 | 0.0956 | 0.092 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0251 | 0.6919 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.014 | 0.3646 | 0.3621 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0048 | 0.0956 | 0.1332 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0037 | 0.0626 | 0.0905 |
Brugia malayi | follicle stimulating hormone receptor | 0.0225 | 0.6149 | 0.8881 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0048 | 0.0956 | 0.092 |
Toxoplasma gondii | melibiase subfamily protein | 0.0107 | 0.2694 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0048 | 0.0956 | 0.092 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.014 | 0.3646 | 0.3621 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0956 | 0.092 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0085 | 0.2023 | 0.8342 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0085 | 0.2023 | 0.8342 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.2694 | 0.2665 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0049 | 0.0988 | 0.0952 |
Schistosoma mansoni | hypothetical protein | 0.0356 | 1 | 1 |
Loa Loa (eye worm) | Smad1 | 0.0017 | 0.0039 | 0.0057 |
Mycobacterium tuberculosis | Probable reductase | 0.0085 | 0.2023 | 0.8342 |
Loa Loa (eye worm) | hypothetical protein | 0.0152 | 0.4022 | 0.5813 |
Loa Loa (eye worm) | glutathione reductase | 0.0037 | 0.0626 | 0.0905 |
Trypanosoma brucei | trypanothione reductase | 0.0037 | 0.0626 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0048 | 0.0956 | 0.092 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0048 | 0.0956 | 0.1381 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.014 | 0.3646 | 0.5269 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0017 | 0.0039 | 0.0057 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0956 | 0.092 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0107 | 0.2694 | 0.2665 |
Echinococcus multilocularis | geminin | 0.0356 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0152 | 0.4022 | 0.5813 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0251 | 0.6919 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.014 | 0.3646 | 0.3621 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0956 | 0.092 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0085 | 0.2023 | 0.8342 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0104 | 0.2603 | 0.3726 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0072 | 0.1642 | 0.1609 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0036 | 0.0604 | 0.0822 |
Loa Loa (eye worm) | glutamate receptor | 0.004 | 0.0715 | 0.1034 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0048 | 0.0956 | 0.092 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0034 | 0.0524 | 0.0487 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0072 | 0.1642 | 0.1609 |
Plasmodium falciparum | glutathione reductase | 0.0037 | 0.0626 | 0.5 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0038 | 0.0641 | 0.0604 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0107 | 0.2694 | 0.2665 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.014 | 0.3646 | 0.3621 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.0034 | 0.0524 | 0.0487 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0094 | 0.2301 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0038 | 0.0641 | 0.0604 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0094 | 0.2301 | 1 |
Brugia malayi | Melibiase family protein | 0.0072 | 0.1642 | 0.233 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0094 | 0.2301 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.2603 | 0.3762 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.002 | 0.0111 | 0.0072 |
Leishmania major | trypanothione reductase | 0.0037 | 0.0626 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0956 | 0.1381 |
Echinococcus granulosus | GPCR family 2 | 0.0048 | 0.0956 | 0.092 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.0034 | 0.0524 | 0.0487 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0085 | 0.2023 | 0.8342 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0107 | 0.2694 | 0.2665 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.014 | 0.3646 | 0.3621 |
Brugia malayi | MH2 domain containing protein | 0.0251 | 0.6919 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.014 | 0.3646 | 0.5243 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0072 | 0.1642 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.2694 | 0.2665 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0037 | 0.0626 | 0.5 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0085 | 0.2023 | 0.8342 |
Plasmodium vivax | glutathione reductase, putative | 0.0037 | 0.0626 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0956 | 0.092 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.014 | 0.3646 | 0.3621 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0094 | 0.2301 | 1 |
Brugia malayi | metabotropic glutamate receptor type 2 | 0.002 | 0.0111 | 0.0104 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0017 | 0.0039 | 0.0057 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.014 | 0.3646 | 0.3621 |
Schistosoma mansoni | hypothetical protein | 0.0356 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.